(Reuters) For hedge fund titan John Paulson, history may be repeating itself.The billionaire investor lost an estimated $258 million on Tuesday when the share price of drug company Allergan Plc (AGN.N) tumbled nearly 15 percent on speculation new tax rules would scuttle its merger with Pfizer Inc. (PFE.N).
Deja Vu For Paulson as Allergan Loss Hurts U.S. Hedge Funds
This entry was posted in Syndicated. Bookmark the permalink.
